-
1
-
-
79955954714
-
Viral induction and targeted inhibition of galectin-1 in EBV+ posttrans-plantation lymphoproliferative disorders
-
Ouyang J, Juszczynski P, Rodig SJ, et al. Viral induction and targeted inhibition of galectin-1 in EBV+ posttrans-plantation lymphoproliferative disorders. Blood. 2011; 117(16):4315-4322.
-
(2011)
Blood
, vol.117
, Issue.16
, pp. 4315-4322
-
-
Ouyang, J.1
Juszczynski, P.2
Rodig, S.J.3
-
2
-
-
16844379997
-
Immunosuppressive networks in the tumour environment and their therapeutic relevance
-
DOI 10.1038/nrc1586
-
Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer. 2005;5(4):263-274. (Pubitemid 40488632)
-
(2005)
Nature Reviews Cancer
, vol.5
, Issue.4
, pp. 263-274
-
-
Zou, W.1
-
3
-
-
67349258025
-
Turning sweet on immunity: Galectin-glycan interactions in immune tolerance and inflammation
-
Rabinovich GA, Toscano MA. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol. 2009;9(5):338-352.
-
(2009)
Nat Rev Immunol
, vol.9
, Issue.5
, pp. 338-352
-
-
Rabinovich, G.A.1
Toscano, M.A.2
-
4
-
-
34548740090
-
The AP1-dependent secretion of galectin-1 by Reed-Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
-
DOI 10.1073/pnas.0706017104
-
Juszczynski P, Ouyang J, Monti S, et al. The AP1- dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad SciU S A. 2007;104(32):13134-13139. (Pubitemid 351737605)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.32
, pp. 13134-13139
-
-
Juszczynski, P.1
Ouyang, J.2
Monti, S.3
Rodig, S.J.4
Takeyama, K.5
Abramson, J.6
Chen, W.7
Kutok, J.L.8
Rabinovich, G.A.9
Shipp, M.A.10
-
5
-
-
34548033053
-
Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma
-
DOI 10.1182/blood-2007-01-066100
-
GandhiMK,Moll G, Smith C, et al. Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. Blood. 2007;110(4):1326-1329. (Pubitemid 47281432)
-
(2007)
Blood
, vol.110
, Issue.4
, pp. 1326-1329
-
-
Gandhi, M.K.1
Moll, G.2
Smith, C.3
Dua, U.4
Lambley, E.5
Ramuz, O.6
Gill, D.7
Marlton, P.8
Seymour, J.F.9
Khanna, R.10
-
6
-
-
65649109738
-
Roles of galectins in infection
-
Vasta GR. Roles of galectins in infection. Nat Rev Microbiol. 2009;7(6):424-438.
-
(2009)
Nat Rev Microbiol
, vol.7
, Issue.6
, pp. 424-438
-
-
Vasta, G.R.1
-
7
-
-
12144285871
-
Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege
-
DOI 10.1016/S1535-6108(04)00024-8, PII S1535610804000248
-
Rubinstein N, Alvarez M, Zwirner NW, et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightenedTcell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell. 2004;5(3):241-251. (Pubitemid 38402116)
-
(2004)
Cancer Cell
, vol.5
, Issue.3
, pp. 241-251
-
-
Rubinstein, N.1
Alvarez, M.2
Zwirner, N.W.3
Toscano, M.A.4
Ilarregui, J.M.5
Bravo, A.6
Mordoh, J.7
Fainboim, L.8
Podhajcer, O.L.9
Rabinovich, G.A.10
-
8
-
-
66149083973
-
Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ Tcells correlates with increased resistance to galectin-1-mediated suppression
-
Smith C, Beagley L, Khanna R. Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ Tcells correlates with increased resistance to galectin-1-mediated suppression. J Virol. 2009;83(12):6192-6198.
-
(2009)
J Virol
, vol.83
, Issue.12
, pp. 6192-6198
-
-
Smith, C.1
Beagley, L.2
Khanna, R.3
-
9
-
-
35549008976
-
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
-
DOI 10.1182/blood-2007-05-091280
-
Bollard CM, Gottschalk S, Leen AM, et al. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer. Blood. 2007;110(8):2838-2845. (Pubitemid 350006936)
-
(2007)
Blood
, vol.110
, Issue.8
, pp. 2838-2845
-
-
Bollard, C.M.1
Gottschalk, S.2
Leen, A.M.3
Weiss, H.4
Straathof, K.C.5
Carrum, G.6
Khalil, M.7
Wu, M.-F.8
Huls, M.H.9
Chang, C.-C.10
Gresik, M.V.11
Gee, A.P.12
Brenner, M.K.13
Rooney, C.M.14
Heslop, H.E.15
-
10
-
-
77649221824
-
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
-
Heslop HE, Slobod KS, Pule MA, et al. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients. Blood. 2010;115(5):925-935.
-
(2010)
Blood
, vol.115
, Issue.5
, pp. 925-935
-
-
Heslop, H.E.1
Slobod, K.S.2
Pule, M.A.3
|